BASECAMP
LIVE

Serial Number

97241251

Owner

ElevateBio, LLC

Attorney

Maury M. Tepper, III

First Use Date

May 13, 2019

Filing Date

Jan 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BASECAMP Trademark

Serial Number: 97241251 • Registration: 7002127

BASECAMP is a trademark filed by ElevateBio, LLC on January 27, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ElevateBio, LLC (14 trademarks)

Cambridge, MA 02142

Entity Type: 16

Trademark Details

Filing Date

January 27, 2022

Registration Date

March 14, 2023

First Use Anywhere

May 13, 2019

First Use in Commerce

May 13, 2019

Published for Opposition

July 26, 2022

Goods & Services

Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 14, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 7, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 6, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 9, 2023 SUPC
USE AMENDMENT FILED
Jan 4, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 4, 2023 EISU
CORRECTED NOA E-MAILED
Oct 13, 2022 NOAC
NOTICE OF ALLOWANCE CORRECTION ENTERED
Oct 12, 2022 ICNA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 12, 2022 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 23, 2022 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2022 CNRT
ASSIGNED TO EXAMINER
May 9, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2022 NWOS
NEW APPLICATION ENTERED
Jan 31, 2022 NWAP